NICE commits to actions following Independent Medicines and Medical Devices Safety Review

The recent Independent Medicines and Medical Devices Safety Review (IMMDS) showed that health technologies are often not used according to best-practice, and NICE has agreed it has a part to play in improving this for the future.

The IMMDS report, called First Do No Harm, showed that following NICE guidelines closely would have prevented harm. The report said:

“more should have been done to ensure that healthcare professionals were aware of and following guidelines. In theory, regulators and professional organisations (such as the CQC, GMC and medical defence unions) reinforce their use through their professional standards and inspection or accreditation processes.”

At its Board meeting, NICE made several key decisions:

“The NICE board supported the need for more work to take place with regulators and professional organisations to reinforce the use of NICE guidance through their professional standards and inspection or accreditation processes.

“… The NICE board… also agreed to the following steps:

  • To consider how to facilitate the production of a single and collaboratively produced patient decision aids
  • To work with NHSX and other system partners to co-create databases and registries which could be used to inform our guideline development
  • For an exceptional review to be carried out on its guideline on the management of urinary incontinence and pelvic organ prolapse in women”
  • Read the IMMDS report for more information, and read NICE’s press release for details on its response.

    Tagged with

    Published on 25. September 2020 in News, News UK, Press Release